GlassScriptPhysician profile
Nicole E Mckenzie
NPI 1184115743
$398.25
in general payments reported to CMS, 2019-2025
8 companies · $205 in 2025
The $205 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $138 · 2023: $34.82 · 2024: $19.48 · 2025: $205.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $260.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $259.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $138.48 | 2022 | |
| Vericel Corporation | $83.52 | 2023-2025 | Nexobrid, Epicel (Cultured Epidermal Autografts) |
| Celgene Corporation | $47.90 | 2025 | Reblozyl |
| Molnlycke Health Care US, LLC | $42.21 | 2025 | Mepilex Ag, Mepilex Border Post-Op Ag, Mepitel Ag |
| Smith+Nephew, INC. | $30.88 | 2025 | Collagenase Santyl |
| Medline Industries LP | $26.82 | 2025 | |
| E.R. Squibb & Sons, L.L.C. | $14.57 | 2025 | Reblozyl |
| Seagen INC. | $13.87 | 2023 | Padcev |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nicole Mckenzie listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.